NOT-NS-23-060: Technical Assistance Webinars for RFA-NS-23-012 "Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Technical Assistance Webinars for RFA-NS-23-012 "Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Notice Number:

NOT-NS-23-060

Key Dates

Release Date:

January 26, 2023

Related Announcements

NOT-NS-23-073 - Notice of Change to Key Dates for RFA-NS-23-012 "Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)"

RFA-NS-23-012 - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The National Institute of Neurological Disorders and Stroke (NINDS) will be hosting pre-application, technical assistance webinars on Wednesday, February 15, from 3PM 4PM (Eastern Time) and on Wednesday, February 22, from 3PM - 4PM (Eastern Time) for all potential applicants interested in the following Funding Opportunity Announcement (FOA):

RFA-NS-23-012 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

This FOA aims to encourage grant applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products. These applications will target EA for intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.

NIH program and review staff will provide an overview of the RFA, including objectives, application instructions and review criteria and will be available to answer questions. Potential applicants who wish to join in the webinar must pre-register for the webinar using the link below.

We request that participants carefully review the funding opportunity for this initiative prior to joining the webinar. Participation in the webinar is optional and is not required for the submission of an application.

Webinar Information

Topic: Technical Assistance Webinar: RFA-23-012 - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Dates: Wednesday, Feb 15, 2023 and Wednesday, Feb 22, 2023

Time: 3PM - 4PM Eastern Time (ET)

To join the webinar, pre-registration is required through the following link: https://nih.zoomgov.com/webinar/register/WN_QWotrbHrRey-eh3FaaCK5g. Please choose the date you would like to attend.

Participants requiring sign language interpretation and/or other reasonable accommodations should contact j [email protected] at least 5 days prior to the event.

Participants can submit questions in advance to Jane Hettinger, [email protected], through the pre-registration link, or during the webinar in the Q&A box.

Event registration, frequently asked questions (FAQs), recordings of the webinar (available after the event), and additional information may be found here: https://www.ninds.nih.gov/news-events/events/informational-webinar-applicants-ninds-als-expanded-access-u01.

Inquiries

Please direct all inquiries to:

Jane Hettinger, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email: [email protected]